UK markets close in 4 hours 2 minutes

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
91.20-0.86 (-0.93%)
At close: 04:00PM EDT
87.70 -3.50 (-3.84%)
Pre-market: 06:33AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,419,226
2,419,226
2,096,039
1,846,275
1,860,455
Cost of revenue
514,854
514,854
483,669
470,515
524,272
Gross profit
1,904,372
1,904,372
1,612,370
1,375,760
1,336,183
Operating expenses
Research development
746,773
746,773
649,606
628,793
628,116
Selling general and administrative
937,300
937,300
854,000
759,400
737,700
Total operating expenses
1,746,273
1,746,273
1,566,406
1,450,093
1,428,016
Operating income or loss
158,099
158,099
45,964
-74,333
-91,833
Interest expense
16,741
16,741
15,377
14,744
27,480
Total other income/expenses net
-10,538
-10,538
101,550
3,846
55,462
Income before tax
188,563
188,563
149,576
-75,350
-48,997
Income tax expense
20,918
20,918
8,015
-11,270
-903,026
Income from continuing operations
167,645
167,645
141,561
-64,080
854,029
Net income
167,645
167,645
141,561
-64,080
854,029
Net income available to common shareholders
167,645
167,645
141,561
-64,080
854,029
Basic EPS
0.77
0.89
0.76
-0.35
4.75
Diluted EPS
0.77
0.87
0.75
-0.35
4.53
Basic average shares
187,222
187,834
185,266
182,852
180,804
Diluted average shares
191,056
191,595
188,963
182,852
191,678